# APL93: Timing of CxT and Role of Maintenance

> **NCT00599937** · PHASE3 · COMPLETED · sponsor: **Groupe d'etude et de travail sur les leucemies aigues promyelocytaires** · enrollment: 576 (actual)

## Conditions studied

- Leukemia, Promyelocytic, Acute

## Interventions

- **DRUG:** ATRA
- **DRUG:** ATRA and or Chemo as maintenance

## Key facts

- **NCT ID:** NCT00599937
- **Lead sponsor:** Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-01
- **Primary completion:** 1998-12
- **Final completion:** 1998-12
- **Target enrollment:** 576 (ACTUAL)
- **Last updated:** 2008-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00599937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00599937, "APL93: Timing of CxT and Role of Maintenance". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00599937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*